A series of focal genetic events seem to lead to the development of neoplastic lesions in large bowel epithelium.' 2 Large bowels affected by neoplasia are also characterised by diffuse changes in the epithelium distant from the tumour. These abnormalities have included increased rates of epithelial proliferation and turnover,2-6 subtle abnormalities of morphology,7 8 and abnormal expression of markers of differentiation.9 Proliferative changes have been directly implicated in the tumorigenic pathway but the significance to tumorigenesis of a change in the biology of differentiating cells is not known. If the mechanisms by which cells develop the abnormalities were defined, then the mechanisms underlying enhanced susceptibility to tumorigenesis might be better understood.
Ulcerative colitis is associated with an enhanced risk of colorectal cancer and some evidence has suggested it too is associated with diffuse abnormalities of large bowel epithelium.10 For example, ultrastructural studies have defined plasma membrane and other abnormalities in epithelium in apparently unaffected areas,11 studies of glycoprotein epitopes and mucin characteristics have also provided evidence for ulcerative colitis specific abnormalities, which occur independently of the presence of mucosal inflammation,12-16 and the rate of rectal epithelial proliferation is increased even in quiescent disease.17 Other studies have shown that there is enhanced expression of markers of differentiation in epithelium from inflamed regions of large bowel although these changes do not seem to be disease specific. [18] [19] [20] [21] The colonic epithelium has a higher turnover and this necessitates cells to rapidly differentiate before being shed into the lumen. There is a paucity of knowledge about factors that influence the rate of differentiation of colonic epithelial cells. We have recently evaluated the use in vitro of two markers of differentiation, the expression of brush border glycoproteins, and the rate of glycoprotein synthesis relative to that of protein synthesis, both of which show increased expression in more differentiated cells.22 Using Just before assaying, cell suspensions or biopsy specimens were mechanically homogenised at 4°C in the mannitol buffer with 0 1% Triton X-1 00. Alkaline phosphatase was measured spectrophotometrically using p-nitrophenol as substrate25 and protein content measured using bovine gamma globulin as standard.26 Alkaline phosphatase activity was expressed relative to cellular protein content and average values for replicate samples were calculated. The coefficient of variation for alkaline phosphatase and protein estimations was <10%.
Assessment of relative rate of synthesis of glycoproteins
Colonic crypt cells were cultured in 96 well U bottomed plates in a total volume of 0-2 ml in 5-6 replicate wells. As these cells cannot be accurately counted because they are anchored to each other in crypt conformation, the number of cells placed in the wells were estimated according to a visual inspection of cell pellet size after the final centrifugation step in the isolation method and varied from population to population. Retrospective analysis of DNA content per well showed this to be in the ,uCi/mmol, 10.4 GBq/mmol, Amersham). The culture was stopped by washing the cells in 1.5 ml Hanks's balanced salt solution and precipitation of protein by the addition of 1 ml of a mixture of 10% trichloracetic acid and 1% phosphotungstic acid (TCA-PTA). The cells were washed twice in the plate and PTA-TCA added directly to the wells. Preparation of the precipitated protein pellets for beta counting then proceeded as previously described. 22 Briefly, the pellets were washed three times with TCA-PTA and twice with a 1:1 mixture of chloroform and methanol. After air drying of the pellet, it was dissolved in 0. 25 Statistical evaluation All analyses were performed using Microstat release 4.1 (Ecosoft Inc, Indianapolis, USA, 1984). Change in indices measured induced by butyrate was expressed as a ratio of the result in the presence to that in the absence of butyrate. Non-parametric data were expressed where appropriate by median value (range). Normally distributed data have been expressed as mean (SEM) and differences between or across groups were evaluated by analysis of variance. Paired/unpaired data were compared using the paired/Student's t test (two sided). A p value 60 05 was considered significant.
Results
Alkaline phosphatase activities and G:P ratios under control conditions Alkaline phosphatase activities measured at the end of 24 hours' culture in homogenates of cells from 74 patients were significantly different across the disease groups (p=0.030). Figure 1 shows the results. Multiple comparisons showed alkaline phosphatase activities to be significantly lower in the cancer group than for ulcerative colitis (p=0.004) and for Crohn's disease (p=0.014), while activities in the normal group tended to differ only from the ulcerative colitis group (p=0.062). Results of the analysis were similar when only data obtained from cells isolated from non-inflamed mucosa in the inflammatory bowel disease patients were analysed. The alkaline phosphatase activities in freshly isolated cells, before initiation of culture, were assessed in a limited number of cell populations (five ulcerative colitis, four normal, and eight cancer) and also showed differences across the groups (p=0 028). Alkaline phosphatase activities in cells from patients with ulcerative colitis (14-0 (4.1) U/g) was significantly higher than those from the cancer group (4.2 (0.7) U/g; p=0006) but not significantly different from that of the normal group (7.35 (2-5) U/g; p=0.12).
The G:P ratio at the end of the culture period under control conditions was assessed in cells isolated from 50 patients and compared across the disease groups. Figure 1 shows the results. No significant differences across the groups were evident (p=050) even when data from non-inflamed mucosa only were examined. When data from cells isolated from inflamed mucosa were excluded, butyrate mediated changes in G:P ratio remained significantly different from those of normal cells (p=0.045) but the difference between the ulcerative colitis and Crohn's disease groups was no longer significant (p=0.23) but only three data points were available for the second group.
Effect of age, region, and mucosal inflammation
There was no significant correlation between age and either alkaline phosphatase activities or G:P ratio, nor between age and butyrate mediated changes in these indices within disease groups or when all cases were considered together. Of all the indices measured, only the G:P ratio showed regional differences when assessed in cells from normal and cancer groups together; the ratio was 3.03 (0.51) (n=10) in the proximal colon, 1.32 (0.45) (n=10) in those from the distal colon, and 1.66 (0.24) (n= 11) in cells from the rectum. This difference was not seen when results from the cancer group alone were analysed.
The expression of alkaline phosphatase after 24 hour culture under control conditions was similar in cells from 22 non-inflamed and 20 from inflamed mucosal specimens (Table II) . The presence of mucosal inflammation also had no apparent effect on the responses of alkaline phosphatase activities and G:P ratios to butyrate. No effect of the presence or absence of mucosal inflammation was seen when results from the ulcerative colitis or Crohn's disease groups were considered separately (data not shown). In additional experiments, seven autologous pairs of cell populations were studied from areas that were either unaffected or non-inflamed, and from inflamed areas. Five of the patients had ulcerative colitis and two Crohn's disease. Alkaline phosphatase activities were 15.0 (4.1) U/g protein from non-inflamed areas, which was similar to that from inflamed areas (16.1 (3.4) U/g protein). Similar analysis of the effect of butyrate on alkaline phosphatase expression showed no apparent effect of mucosal inflammation (1.02 (0.03) versus 092 (0.08), respectively). In the ulcerative colitis group, results were similar in cells from apparently normal (n=8) and currently non-inflamed mucosa (n=6) for both alkaline phosphatase activities (11-2 (3.5) U/g versus 8.4 (4.7) U/g; p=0.31) and butyrate mediated changes (1.02 (0.03) versus 0.95 (0.06), respectively; p=014).
The effect of mucosal inflammation on the G:P ratio was assessed in 11 cell populations obtained from non-inflamed mucosa and six from inflamed mucosa. No differences were evident (Table II) . Likewise, there was no difference between the effect of butyrate on G:P ratio (Table II) were not apparent in the response of G:P ratio to butyrate in cells from apparently unaffected mucosa of patients with ulcerative colitis (1.00 (0.04)) and from previously involved but currently non-inflamed mucosa (1 - Evidence that diffuse epithelial abnormalities are present in colorectal neoplasia is strong; abnormal findings, such as increased rate of proliferation,3-6 abnormal morphology,7 8 and abnormal mucosal brush border hydrolase expression,9 are found in vivo, and responses to butyrate, such as an enhanced suppressive effect of butyrate on urokinase secretion and a blunted stimulatory effect on plasminogen activator inhibitor 1 secretion,31 are present in vitro. Now abnormal butyrate mediated effects on markers of differentiation can be added to the list. The biological basis for such responses to butyrate is poorly understood.
Abnormal patterns of results were also seen for cells from ulcerative colitis patients. Butyrate suppressed G:P ratio and this response was significantly different from that in the normal group. This effect was disease specific as the response to butyrate in the Crohn's disease group was normal and also differed significantly from that in the ulcerative colitis group. The abnormal response seen does not simply mimic that seen for cells from the cancer group -alkaline phosphatase activities were unaffected by butyrate -and, therefore, is less easily explained by a butyrate mediated suppression of pathways of differentiation.
The biological significance of small changes The basis for such abnormalities are not defined although a twin study has shown some mucin abnormalities to be genetically determined.'3 Whatever the mechanism, the presence of such epithelial abnormalities independently of the presence of mucosal inflammation supports the hypothesis that abnormalities of colonic epithelium are early events in the pathogenesis of ulcerative colitis.
The biological significance of the findings made in this study, apart from highlighting diffuse epithelial abnormalities in ulcerative colitis and colorectal cancer, is unclear. A key finding in both diseases in the increased rate of proliferation of colonic epithelial cells.3-6 17 34-36 An important event that controls proliferation of hierarchal cells like colonic epithelium is the rate of cell death. Apoptosis occurs as the final stage in the differentiation of keratinocytes.37 If apoptosis and differentiation are processes in the same pathway in colonic epithelium, and in situ labelling of DNA fragmentation would suggest it is so,38 acceleration of the differentiation process suggested by the in vitro findings of this study might be associated with accelerated cell death and subsequent increase in the rate cell proliferation. Defining the molecular basis for such abnormality might therefore, provide important clues to pathogenic events in ulcerative colitis and in colorectal tumorigenesis.
In conclusion, 24 hour exposure of normal colonic crypt cells to butyrate in vitro has no effect on their expression of markers of differentiation. The previously described butyrate mediated suppression of differentiation in colonic crypt cells from cancer bearing colons is, therefore, an abnormal response. An inflammation independent, disease specific abnormality of the response of G:P ratio to butyrate was seen in colonic crypt cells from patients with ulcerative colitis. These results provide further evidence for diffuse but differing abnormalities of colonic epithelium in both ulcerative colitis and colorectal carcinoma.
